These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11280377)

  • 1. Cutaneous DNA vaccination against Ebola virus by particle bombardment: histopathology and alteration of CD3-positive dendritic epidermal cells.
    Steele KE; Stabler K; VanderZanden L
    Vet Pathol; 2001 Mar; 38(2):203-15. PubMed ID: 11280377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
    Vanderzanden L; Bray M; Fuller D; Roberts T; Custer D; Spik K; Jahrling P; Huggins J; Schmaljohn A; Schmaljohn C
    Virology; 1998 Jun; 246(1):134-44. PubMed ID: 9657001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.
    Mellquist-Riemenschneider JL; Garrison AR; Geisbert JB; Saikh KU; Heidebrink KD; Jahrling PB; Ulrich RG; Schmaljohn CS
    Virus Res; 2003 Apr; 92(2):187-93. PubMed ID: 12686428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse.
    Dincer Z; Jones S; Haworth R
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):351-7. PubMed ID: 16713213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization for Ebola virus infection.
    Xu L; Sanchez A; Yang Z; Zaki SR; Nabel EG; Nichol ST; Nabel GJ
    Nat Med; 1998 Jan; 4(1):37-42. PubMed ID: 9427604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
    Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
    J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.
    Bradfute SB; Anthony SM; Stuthman KS; Ayithan N; Tailor P; Shaia CI; Bray M; Ozato K; Bavari S
    PLoS One; 2015; 10(3):e0118434. PubMed ID: 25785602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a preventive vaccine for Ebola virus infection in primates.
    Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
    Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola virus-like particles protect from lethal Ebola virus infection.
    Warfield KL; Bosio CM; Welcher BC; Deal EM; Mohamadzadeh M; Schmaljohn A; Aman MJ; Bavari S
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15889-94. PubMed ID: 14673108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium.
    Chen SC; Fynan EF; Greenberg HB; Herrmann JE
    Vaccine; 1999 Aug; 17(23-24):3171-6. PubMed ID: 10462253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice.
    Wong G; Qiu X; Ebihara H; Feldmann H; Kobinger GP
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S435-42. PubMed ID: 26022441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus].
    Chepurnov AA; Ternovoĭ VA; Dadaeva AA; Dmitriev IP; Sizikova LP; Volchkov VE; Kudoiarova NM; Rudzevich TN; Netesov SV
    Vopr Virusol; 1997; 42(3):115-20. PubMed ID: 9297340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.
    Dean HJ; Fuller D; Osorio JE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):373-88. PubMed ID: 12818623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
    Kobinger GP; Feldmann H; Zhi Y; Schumer G; Gao G; Feldmann F; Jones S; Wilson JM
    Virology; 2006 Mar; 346(2):394-401. PubMed ID: 16356525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.